Republican Congressional Committee members question MACPAC leadership’s conflicts of interest.
Republicans on the House of Representatives Energy and Commerce Committee are raising questions about the selection process for members of the Medicaid and CHIP Payment and Access Commission (MACPAC) commission, which recommends Medicaid policy to Congress, and expressed concerns that “there may be conflicts of interest on the panel of experts that is supposed to be independent.”
Committee Chairman Fred Upton (R-MI) and Health Subcommittee Chairman Joe Pitts (R-PA) wrote letters to the Comptroller General of the US Government Accountability Office (GAO) and the leaders of MACPAC saying that MACPAC does not have a “sufficient” conflict of interest policy and that they had concerns about the way the head of the GAO selects new commissioners.
“Without a balance of commissioners and a robust conflict of interest policy, we believe MACPAC’s recommendations will lack a needed level of independence and integrity,” the letter to MACPAC stated.
The letter to the GAO head said the Congressmen wanted to better understand GAO’s process and methodology for evaluating candidates and making appointments to MACPAC, and included a request for what steps GAO has taken to comply with the requirement for public disclosure by members of MACPAC of financial and other potential conflicts of interest relating to such members.
The letter to GAO’s head also asked if GAO examines or evaluates “the degree to which candidates have participated in advocacy or political activity that could result in a perceived or real conflict of interest and thus compromise the independence and integrity of MACPAC recommendations.” The committee members said they are not aware of any required disclosure or recusal process at MACPAC related to a commissioner’s political activity or advocacy.
The Congressmen’s letter said they found it to be a significant conflict of interest that newly appointed chair of MACPAC, Sara Rosenbaum, has joined an amicus brief in support of the administration against the US House of Representatives in a lawsuit filed against the White House. The lawsuit claims that the administration violated the law by creating subsidies under the Affordable Care Act (ACA) that were not specifically appropriated by Congress.
The Republican committee members are concerned that they are not getting the kinds of robust, independent analyses from MACPAC on issues concerning Medicaid that helps them properly oversee the program and make changes when needed.
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis
March 15th 2025The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the indication to include pediatric patients who are 6 years or older and positive for antiacetylcholine receptor antibodies.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More